SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 12, 2004 (May 12, 2004)
ENDO PHARMACEUTICALS HOLDINGS INC.
| DELAWARE | 001-15989 | 13-4022871 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
||
| 100 Painters Drive Chadds Ford, Pennsylvania |
19317 |
|||
| (Address of principal executive offices) | (Zip Code) | |||
(610) 558-9800
N/A
| Item 7. Financial Statements and Exhibits. | ||||||||
| Item 9. Regulation FD Disclosure. | ||||||||
| SIGNATURES | ||||||||
| INDEX TO EXHIBITS | ||||||||
| EX-99.1: SLIDE PRESENTATION | ||||||||
Item 7. Financial Statements and Exhibits.
| (a) | Financial Statements of Business Acquired. |
Not applicable.
| (b) | Pro Forma Financial Information. |
Not applicable.
| (c) | Exhibits. |
| Exhibit Number | Description | |
99.1
|
Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated May 12, 2004 |
Item 9. Regulation FD Disclosure.
On May 12, 2004, the Registrant intends to make a slide presentation at the NASDAQ Life Sciences Forum in London, England, a copy of which presentation is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| ENDO PHARMACEUTICALS HOLDINGS INC. (Registrant) |
||||||
| By: | /s/ CAROL A. AMMON | |||||
| Name: | Carol A. Ammon | |||||
| Title: | Chairman & Chief Executive Officer | |||||
Dated: May 12, 2004